Physician profile
Kyle L Dale
NPI 1295916120
$2,465.07
in general payments reported to CMS, 2019-2025
8 companies · $1,646 in 2025
The $1,646 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $55.75 · 2021: $313 · 2022: $15.08 · 2023: $25.79 · 2024: $200 · 2025: $1,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,236 · Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,235.91 |
| Food and Beverage | $635.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $1,479.31 | 2019-2025 | Glidesheath Slender, Angio-Seal |
| Sirtex Medical INC | $368.61 | 2020-2021 | |
| Rapid Medical LTD | $168.22 | 2025 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Stryker Corporation | $160.41 | 2019-2025 | Trevo, Broadway 8, Axs Vecta 71 |
| Siemens Medical Solutions USA, INC. | $87.57 | 2024 | Somatom Pro.Pulse |
| Inari Medical, INC. | $87.50 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.76 | 2019 | |
| Boston Scientific Corporation | $51.69 | 2023-2025 | Icefx Cryoablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Dale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.